Key result
In neonatal rat ventricular cardiomyocytes, the trophic effects of Angiotensin II are mediated via local Endothelin-1 secretion upon AT1-receptor stimulation in non-myocyte cells.
The trophic effects of Angiotensin II on neonatal rat ventricular cardiomyocytes are mediated via local endothelin-1 secretion from non-myocyte cells upon AT1-receptor stimulation.
Answers are grounded in this paper and cite their sources.
Does not inform clinical practice; leaves open ET-1 mediation of Ang II effects in adult human cardiomyocytes.
Angiotensin II (AII) and the endothelins (ET) are known to be potent trophic stimuli in various cells including cardiomyocytes. In order to characterize further these effects we studied, in neonatal rat ventricular cardiomyocytes, the effects of several endothelin-receptor antagonists and the AT1-receptor antagonist losartan on AII- and endothelin-induced inositol phosphate (IP)-formation (assessed as accumulation of total [3H]-IPs in myo-[3H]-inositol prelabelled cells) and increase in rate of protein synthesis (assessed as [3H]-phenylalanine incorporation). 2. Endothelin (10 pM-1 microM) concentration-dependently increased IP-formation (max. increase at 100 nM ET-1: 130 +/- 14% above basal, n = 25) and [3H]-phenylalanine incorporation (max. increase at 1 microM: 52 +/- 4% above basal, n = 16) with an order of potency: ET-1 > > ET-3. Both effects were antagonized by the ETA/ETB-receptor antagonist bosentan and the ETA-receptor antagonist BQ-123, but not affected by the ETB-receptor antagonist IRL 1038 and the AT1-receptor antagonist losartan. 3. Pretreatment of the cells with 500 ng ml-1 pertussis toxin (PTX) overnight that completely inactivated PTX-sensitive G-proteins did not attenuate but rather enhance ET-1-induced IP-formation. On the other hand, in PTX-pretreated cardiomyocytes ET-1-induced [3H]-phenylalanine incorporation was decreased by 39 +/- 5% (n = 5). 4. All (1 nM-1 microM) concentration-dependently increased IP-formation (max. increase at 1 microM: 42 +/- 7% above basal, n = 16) and [3H]-phenylalanine incorporation (max. increase at 1 microM: 29 +/- 2%, n = 9). These effects were antagonized by losartan, but they were also antagonized by bosentan and BQ-123. 5. In well-defined cultures of cardiomyocytes (not contaminated with non-myocyte cells) All failed to increase [3H]-phenylalanine incorporation: addition of non-myocyte cells to the cardiomyocytes restored All-induced increase in [3H]-phenylalanine incorporation. 6. We conclude that, in rat neonatal ventricular cardiomyocytes, (a) the ET-1-induced increase in rate of protein synthesis (through ETA-receptor stimulation) involves at least two signalling pathways: one via a PTX-insensitive G-protein coupled to IP-formation, and the other one via a PTX-sensitive G-protein, and (b) the trophic effects of All are brought about via local ET-1 secretion upon AT1-receptor stimulation in neonatal rat ventricular non-myocyte cells.
No takes yet. Share an insight, caveat, or question.
Pönicke et al. (1997) studied Neonatal rat cardiomyocytes (in vitro). Angiotensin II and Endothelin-1 vs. Basal / receptor antagonists (bosentan, BQ-123, IRL 1038, losartan) was evaluated on Inositol phosphate (IP)-formation and rate of protein synthesis ([3H]-phenylalanine incorporation). In neonatal rat ventricular cardiomyocytes, the trophic effects of Angiotensin II are mediated via local Endothelin-1 secretion upon AT1-receptor stimulation in non-myocyte cells.
Synapse has enriched 10 related papers. Consider them for comparative context: